Inventor · disambiguated record
Palaniswami Rathanaswami
Also filed as: RATHANASWAMI PALANISWAMI
14 granted patents·4 pending applications·405 citations·filing 2003–2020
94Inventor score
Top patents by PatentIndex Score
18 records- 0197US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0297US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0395US7285269B2Antibodies directed to tumor necrosis factorAMGEN FREMONT INC·Filed 2003·Granted Oct 23, 2007·101 cites·35 claims
- 0494US7585500B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2005·Granted Sep 8, 2009·36 cites·3 claims
- 0593US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 0691US8604174B2High affinity fully human monoclonal antibodies to interleukin-8BABCOOK JOHN·Filed 2006·Granted Dec 10, 2013·30 cites·7 claims
- 0788US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 0886US7994302B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2009·Granted Aug 9, 2011·8 cites·8 claims
- 0982US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 1081US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 1181US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 1280US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 1375US10508153B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2015·Granted Dec 17, 2019·1 cites·61 claims
- 1474US8101178B2Antibodies directed to tumor necrosis factor and uses thereofBABCOOK JOHN S·Filed 2007·Granted Jan 24, 2012·3 cites·21 claims
- 1552US2014105905A1High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such AntibodiesAMGEN FREMONT INC·Filed 2013·Application pending·0 cites
- 1651US2010233154A1Targeted binding agents directed to heparanase and uses thereof 463MEDIMMUNE LTD·Filed 2009·Application pending·0 cites
- 1749US2022281966A1Anti-il13 antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 1839US2014314784A1Anti-cxcr4 antibodies and methods of useBEDIAN VAHE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Palaniswami Rathanaswami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →